ASCO 2015 Highlights

Ceritinib in Advanced ALK-Rearranged NSCLC: Results from the ASCEND-1 Trial

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Docetaxel and Cisplatin Plus Chemoradiation in Inoperable Stage III NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Results from RADIANT: Adjuvant Erlotinib in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

Breaking News from the REVEL Study in NSCLC

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

NSCLC Daily News from ASCO 2014: May 30, 2014 – Preview of Key Topics

ASCO 2014 – Lung Cancer, ASCO

Conference Correspondent

mCRC Daily News from ASCO 2014: May 30, 2014 - Preview of Key Topics

ASCO 2014 – Colorectal and Head & Neck Cancer, ASCO

Conference Correspondent

Immuno-Oncology: The New Frontier?

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Ipilimumab Combined with Cytotoxic Chemotherapy in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Doublets and Triple Combinations in Metastatic Melanoma

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Stereotactic Radiosurgery and Ipilimumab for Melanoma Brain Metastases

ASCO 2014 – Immuno-Oncology, ASCO

Conference Correspondent

Page 229 of 329